These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 21296514

  • 1. Comparison of three different injection methods for arterial phase of Gd-EOB-DTPA enhanced MR imaging of the liver.
    Tamada T, Ito K, Yoshida K, Kanki A, Higaki A, Tanimoto D, Higashi H.
    Eur J Radiol; 2011 Dec; 80(3):e284-8. PubMed ID: 21296514
    [Abstract] [Full Text] [Related]

  • 2. Dilution method of gadolinium ethoxybenzyl diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI).
    Motosugi U, Ichikawa T, Sou H, Sano K, Ichikawa S, Tominaga L, Araki T.
    J Magn Reson Imaging; 2009 Oct; 30(4):849-54. PubMed ID: 19787734
    [Abstract] [Full Text] [Related]

  • 3. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
    Tamada T, Ito K, Sone T, Yamamoto A, Yoshida K, Kakuba K, Tanimoto D, Higashi H, Yamashita T.
    J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
    [Abstract] [Full Text] [Related]

  • 4. Liver vessel enhancement by Gd-BOPTA and Gd-EOB-DTPA: a comparison in healthy volunteers.
    Brismar TB, Dahlstrom N, Edsborg N, Persson A, Smedby O, Albiin N.
    Acta Radiol; 2009 Sep; 50(7):709-15. PubMed ID: 19701821
    [Abstract] [Full Text] [Related]

  • 5. Potential clinical factors affecting hepatobiliary enhancement at Gd-EOB-DTPA-enhanced MR imaging.
    Higaki A, Tamada T, Sone T, Kanki A, Sato T, Tanimoto D, Higashi H, Ito K.
    Magn Reson Imaging; 2012 Jun; 30(5):689-93. PubMed ID: 22459437
    [Abstract] [Full Text] [Related]

  • 6. Gd-EOB-DTPA enhanced MR imaging: evaluation of biliary and renal excretion in normal and cirrhotic livers.
    Tamada T, Ito K, Sone T, Kanki A, Sato T, Higashi H.
    Eur J Radiol; 2011 Dec; 80(3):e207-11. PubMed ID: 20869827
    [Abstract] [Full Text] [Related]

  • 7. Hepatic hemangiomas: difference in enhancement pattern on 3T MR imaging with gadobenate dimeglumine versus gadoxetate disodium.
    Gupta RT, Marin D, Boll DT, Husarik DB, Davis DE, Feuerlein S, Merkle EM.
    Eur J Radiol; 2012 Oct; 81(10):2457-62. PubMed ID: 22138122
    [Abstract] [Full Text] [Related]

  • 8. Hepatocellular MR contrast agents: enhancement characteristics of liver parenchyma and portal vein after administration of gadoxetic acid in comparison to gadobenate dimeglumine.
    Feuerlein S, Gupta RT, Boll DT, Merkle EM.
    Eur J Radiol; 2012 Sep; 81(9):2037-41. PubMed ID: 21719224
    [Abstract] [Full Text] [Related]

  • 9. Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents.
    Husarik DB, Gupta RT, Ringe KI, Boll DT, Merkle EM.
    Acad Radiol; 2011 Dec; 18(12):1549-54. PubMed ID: 21958599
    [Abstract] [Full Text] [Related]

  • 10. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers.
    Tamada T, Ito K, Higaki A, Yoshida K, Kanki A, Sato T, Higashi H, Sone T.
    Eur J Radiol; 2011 Dec; 80(3):e311-6. PubMed ID: 21315529
    [Abstract] [Full Text] [Related]

  • 11. [Renal enhancement and excretion of the hepatobiliary contrast agent Gd-EOB-DTPA].
    Zangos S, Hammerstingl R, Mack MG, Straub R, Engelmann K, Eichler K, Balzer T, Vogl TJ.
    Rofo; 2001 Nov; 173(11):1034-40. PubMed ID: 11704914
    [Abstract] [Full Text] [Related]

  • 12. Optimization of the dynamic, Gd-EOB-DTPA-enhanced MRI of the liver: the effect of the injection rate.
    Schmid-Tannwald C, Herrmann K, Oto A, Panteleon A, Reiser M, Zech C.
    Acta Radiol; 2012 Nov 01; 53(9):961-5. PubMed ID: 23024179
    [Abstract] [Full Text] [Related]

  • 13. T2-weighted magnetic resonance imaging of the liver: evaluation of the effect in signal intensity after Gd-EOB-DTPA enhancement.
    Tamada T, Ito K, Yoshida K, Sone T, Murakami K, Kanki A, Watanabe S, Higashi H, Yamashita T.
    J Comput Assist Tomogr; 2010 Nov 01; 34(2):182-6. PubMed ID: 20351500
    [Abstract] [Full Text] [Related]

  • 14. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N, Persson A, Albiin N, Smedby O, Brismar TB.
    Acta Radiol; 2007 May 01; 48(4):362-8. PubMed ID: 17453513
    [Abstract] [Full Text] [Related]

  • 15. Contrast agent Gd-EOB-DTPA (EOB·Primovist®) for low-field magnetic resonance imaging of canine focal liver lesions.
    Yonetomi D, Kadosawa T, Miyoshi K, Nakao Y, Homma E, Hanazono K, Yamada E, Nakamura K, Ijiri A, Minegishi N, Maetani S, Hirayama K, Taniyama H, Nakade T.
    Vet Radiol Ultrasound; 2012 May 01; 53(4):371-80. PubMed ID: 22548505
    [Abstract] [Full Text] [Related]

  • 16. Timing of the hepatic arterial phase at Gd-EOB-DTPA-enhanced hepatic dynamic MRI: comparison of the test-injection and the fixed-time delay method.
    Nakamura S, Nakaura T, Kidoh M, Utsunomiya D, Doi Y, Harada K, Uemura S, Yamashita Y.
    J Magn Reson Imaging; 2013 Sep 01; 38(3):548-54. PubMed ID: 23744782
    [Abstract] [Full Text] [Related]

  • 17. New proposal for the staging of nonalcoholic steatohepatitis: evaluation of liver fibrosis on Gd-EOB-DTPA-enhanced MRI.
    Tsuda N, Okada M, Murakami T.
    Eur J Radiol; 2010 Jan 01; 73(1):137-42. PubMed ID: 19026502
    [Abstract] [Full Text] [Related]

  • 18. Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.
    Frericks BB, Loddenkemper C, Huppertz A, Valdeig S, Stroux A, Seja M, Wolf KJ, Albrecht T.
    AJR Am J Roentgenol; 2009 Oct 01; 193(4):1053-60. PubMed ID: 19770329
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and imaging properties of Gd-EOB-DTPA in patients with hepatic and renal impairment.
    Gschwend S, Ebert W, Schultze-Mosgau M, Breuer J.
    Invest Radiol; 2011 Sep 01; 46(9):556-66. PubMed ID: 21623212
    [Abstract] [Full Text] [Related]

  • 20. Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis.
    Kanki A, Tamada T, Higaki A, Noda Y, Tanimoto D, Sato T, Higashi H, Ito K.
    Magn Reson Imaging; 2012 Apr 01; 30(3):356-60. PubMed ID: 22227353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.